|
DIAPH3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.333670E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.417770E-02 |
| Normal-vs-Stage2 |
5.279600E-01 |
| Normal-vs-Stage3 |
5.381100E-03 |
| Normal-vs-Stage4 |
8.063900E-03 |
| Stage1-vs-Stage2 |
2.182100E-02 |
| Stage1-vs-Stage3 |
5.229800E-01 |
| Stage1-vs-Stage4 |
2.967800E-01 |
| Stage2-vs-Stage3 |
1.012000E-02 |
| Stage2-vs-Stage4 |
1.084280E-02 |
| Stage3-vs-Stage4 |
6.508600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.343800E-03 |
| Normal-vs-AfricanAmerican |
1.800220E-01 |
| Normal-vs-Asian |
6.926500E-02 |
| Caucasian-vs-AfricanAmerican |
1.293390E-01 |
| Caucasian-vs-Asian |
1.452970E-01 |
| AfricanAmerican-vs-Asian |
7.015800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.635700E-03 |
| Normal-vs-Female |
1.796480E-02 |
| Male-vs-Female |
5.328800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.823700E-03 |
| Normal-vs-Age(41-60Yrs) |
9.220100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.944500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.677980E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.055400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.312170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.082400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.519000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.722200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.718300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.974020E-01 |
| Classical-VS-Follicular |
1.56140000040494E-07 |
| Classical-VS-Other |
5.454200E-01 |
| Classical-VS-Normal |
3.496200E-03 |
| Tall-VS-Follicular |
2.551100E-04 |
| Tall-VS-Other |
2.407600E-01 |
| Tall-VS-Normal |
3.177700E-03 |
| Follicular-VS-Other |
2.969000E-01 |
| Follicular-VS-Normal |
7.956200E-01 |
| Other-VS-Normal |
4.663000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.085800E-02 |
| Normal-vs-N1 |
3.130100E-02 |
| N0-vs-N1 |
3.822000E-01 |
|
|
